CU6 0.23% $8.74 clarity pharmaceuticals ltd

Yeah for sure and it will be interesting to see how the PSA...

  1. 4,994 Posts.
    lightbulb Created with Sketch. 339
    Yeah for sure and it will be interesting to see how the PSA reduction translates to PFS and OS.

    TLX591 showed only modest initial PSA reductions compared to pluvicto and indeed copper but still had superior PFS to pluvicto.

    Then with TLX591 you see that delayed and extended effect likely due to extended retention.

    Maybe cu6 will get a similar extended effect.

    All so interesting.



 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.